402 related articles for article (PubMed ID: 27838289)
1. Biopharmaceuticals from microorganisms: from production to purification.
Jozala AF; Geraldes DC; Tundisi LL; Feitosa VA; Breyer CA; Cardoso SL; Mazzola PG; Oliveira-Nascimento L; Rangel-Yagui CO; Magalhães PO; Oliveira MA; Pessoa A
Braz J Microbiol; 2016 Dec; 47 Suppl 1(Suppl 1):51-63. PubMed ID: 27838289
[TBL] [Abstract][Full Text] [Related]
2. Biosimilars: opportunity or cause for concern?
Roger SD; Mikhail A
J Pharm Pharm Sci; 2007; 10(3):405-10. PubMed ID: 17727803
[TBL] [Abstract][Full Text] [Related]
3. Biopharmaceutical benchmarks 2018.
Walsh G
Nat Biotechnol; 2018 Dec; 36(12):1136-1145. PubMed ID: 30520869
[No Abstract] [Full Text] [Related]
4. Pharmaceutical biotechnology products approved within the European Union.
Walsh G
Eur J Pharm Biopharm; 2003 Jan; 55(1):3-10. PubMed ID: 12551698
[TBL] [Abstract][Full Text] [Related]
5. Biopharmaceuticals derived from genetically modified plants.
Goldstein DA; Thomas JA
QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
[TBL] [Abstract][Full Text] [Related]
6. Biosimilars: recent developments.
Covic A; Kuhlmann MK
Int Urol Nephrol; 2007; 39(1):261-6. PubMed ID: 17333516
[TBL] [Abstract][Full Text] [Related]
7. Developments and opportunities in continuous biopharmaceutical manufacturing.
Khanal O; Lenhoff AM
MAbs; 2021; 13(1):1903664. PubMed ID: 33843449
[TBL] [Abstract][Full Text] [Related]
8. Biopharmaceuticals in China.
Hu X; Ma Q; Zhang S
Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435
[TBL] [Abstract][Full Text] [Related]
9. The biopharmaceutical industry in China: history and future perspectives.
Gao K; Wang J
Front Med; 2012 Jun; 6(2):101-11. PubMed ID: 22544299
[TBL] [Abstract][Full Text] [Related]
10. A Brief Talk on the Design of Biopharmaceutical Separation and Purification Technology Course.
He Y; White M; Gang W; Yan S
J Healthc Eng; 2022; 2022():9728071. PubMed ID: 35087652
[TBL] [Abstract][Full Text] [Related]
11. Exploring the potential of machine learning for more efficient development and production of biopharmaceuticals.
Puranik A; Dandekar P; Jain R
Biotechnol Prog; 2022 Nov; 38(6):e3291. PubMed ID: 35918873
[TBL] [Abstract][Full Text] [Related]
12. Bioreactor technology: a novel industrial tool for high-tech production of bioactive molecules and biopharmaceuticals from plant roots.
Sivakumar G
Biotechnol J; 2006 Dec; 1(12):1419-27. PubMed ID: 17136730
[TBL] [Abstract][Full Text] [Related]
13. Continuous downstream processing of biopharmaceuticals.
Jungbauer A
Trends Biotechnol; 2013 Aug; 31(8):479-92. PubMed ID: 23849674
[TBL] [Abstract][Full Text] [Related]
14. Interferon-Based Biopharmaceuticals: Overview on the Production, Purification, and Formulation.
Castro LS; Lobo GS; Pereira P; Freire MG; Neves MC; Pedro AQ
Vaccines (Basel); 2021 Apr; 9(4):. PubMed ID: 33915863
[TBL] [Abstract][Full Text] [Related]
15. Assessing the Immunogenicity of Biopharmaceuticals.
Pineda C; Castañeda Hernández G; Jacobs IA; Alvarez DF; Carini C
BioDrugs; 2016 Jun; 30(3):195-206. PubMed ID: 27097915
[TBL] [Abstract][Full Text] [Related]
16. Production of Biopharmaceuticals in E. coli: Current Scenario and Future Perspectives.
Baeshen MN; Al-Hejin AM; Bora RS; Ahmed MM; Ramadan HA; Saini KS; Baeshen NA; Redwan EM
J Microbiol Biotechnol; 2015 Jul; 25(7):953-62. PubMed ID: 25737124
[TBL] [Abstract][Full Text] [Related]
17. The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape.
Moorkens E; Meuwissen N; Huys I; Declerck P; Vulto AG; Simoens S
Front Pharmacol; 2017; 8():314. PubMed ID: 28642701
[No Abstract] [Full Text] [Related]
18. Biotechnological Production of Pharmaceuticals and Biopharmaceuticals in Plant Cell and Organ Cultures.
Hidalgo D; Sanchez R; Lalaleo L; Bonfill M; Corchete P; Palazon J
Curr Med Chem; 2018; 25(30):3577-3596. PubMed ID: 29521202
[TBL] [Abstract][Full Text] [Related]
19. Plants as bioreactors for biopharmaceuticals: regulatory considerations.
Miele L
Trends Biotechnol; 1997 Feb; 15(2):45-50. PubMed ID: 9081298
[TBL] [Abstract][Full Text] [Related]
20. Recombinant plant-derived pharmaceutical proteins: current technical and economic bottlenecks.
Sabalza M; Christou P; Capell T
Biotechnol Lett; 2014 Dec; 36(12):2367-79. PubMed ID: 25048244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
